Cargando…

Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses

Previous studies have revealed that several micro-organisms, especially DNA viruses, have been associated with adult-onset Still's disease (AOSD). However, there are no studies on the relationship between the presence of viral infections in AOSD patients with disease occurrence and reactivation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Jinchao, Shi, Hui, Liu, Mengguo, Liu, Tingting, Gu, Jieyu, Wan, Liyan, Teng, Jialin, Liu, Honglei, Cheng, Xiaobing, Ye, Junna, Su, Yutong, Sun, Yue, Gong, Wen, Yang, Chengde, Hu, Qiongyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491741/ https://www.ncbi.nlm.nih.gov/pubmed/31068953 http://dx.doi.org/10.3389/fimmu.2019.00898

Ejemplares similares

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Total metabolic lesion volume of lymph nodes measured by (18)F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease
por: Wan, Liyan, et al.
Publicado: (2021)

Pregnancy Outcomes in Patients With Adult-Onset Still's Disease: A Cohort Study From China
por: Wang, Zhihong, et al.
Publicado: (2020)

Differential diagnostic performance of PET/CT in adult-onset still’s disease and lymphoma: a retrospective pilot study
por: Wan, Liyan, et al.
Publicado: (2022)

Association of the Leukocyte Immunoglobulin‐like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult‐Onset Still’s Disease
por: Wang, Mengyan, et al.
Publicado: (2021)

Serum sTREM-1 in adult-onset Still’s disease: a novel biomarker of disease activity and a potential predictor of the chronic course
por: Wang, Zhihong, et al.
Publicado: (2020)

Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
por: Hu, Qiongyi, et al.
Publicado: (2020)

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

Neutrophil-derived lipocalin-2 in adult-onset Still’s disease: a novel biomarker of disease activity and liver damage
por: Jia, Jinchao, et al.
Publicado: (2020)

Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still’s disease
por: Hu, Qiongyi, et al.
Publicado: (2019)

Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still’s disease pathogenesis
por: Jia, Jinchao, et al.
Publicado: (2022)

Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still’s Disease: A Machine Learning Study
por: Jia, Jinchao, et al.
Publicado: (2020)

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
por: Meng, Jianfen, et al.
Publicado: (2021)

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease
por: Su, Yutong, et al.
Publicado: (2019)

Current and emerging biological therapy in adult-onset Still’s disease
por: Ma, Yuning, et al.
Publicado: (2021)

A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on Prognosis
por: Chi, Huihui, et al.
Publicado: (2020)

Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis
por: Hu, Qiongyi, et al.
Publicado: (2019)

“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
por: Liu, Tingting, et al.
Publicado: (2020)

Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients
por: Shi, Hui, et al.
Publicado: (2017)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Methylenetetrahydrofolate Reductase 677T Allele Is a Risk Factor for Arterial Thrombosis in Chinese Han Patients with Antiphospholipid Syndrome
por: Tang, Zihan, et al.
Publicado: (2022)

The clinical pattern differentiates ANCA-positive infective endocarditis patients from ANCA-associated vasculitis patients: a 23 years’ retrospective cohort study in China and follow-ups
por: Wang, Fan, et al.
Publicado: (2022)

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker
por: Hu, Qiongyi, et al.
Publicado: (2018)

Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still’s Disease From Sepsis
por: Tian, Rui, et al.
Publicado: (2021)

Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
por: Teng, Jialin, et al.
Publicado: (2020)

Evaluating hypercoagulability in new‐onset systemic lupus erythematosus patients using thromboelastography
por: Gong, Huiyun, et al.
Publicado: (2019)

Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Delayed-onset of progressive pseudorheumatoid dysplasia in a Chinese adult with a novel compound WISP3 mutation: a case report
por: Hu, Qiongyi, et al.
Publicado: (2017)

Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients
por: Han, Jing, et al.
Publicado: (2022)

COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study
por: Pan, Haoyu, et al.
Publicado: (2022)

Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still's disease in Chinese individuals
por: Li, Zhiqiang, et al.
Publicado: (2020)

Continuation, reduction, or withdrawal of tofacitinib in patients with rheumatoid arthritis achieving sustained disease control: a multicenter, open-label, randomized controlled trial
por: Wang, Mengyan, et al.
Publicado: (2023)

Tozinameran: Relapse of adult-onset Still's disease: case report
Publicado: (2022)

Value of the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the inflammatory myopathy population
por: Shi, Yunjing, et al.
Publicado: (2023)

Pulmonary artery hypertension prior to the relapse of adult‐onset Still's disease
por: Hara, Yuki, et al.
Publicado: (2021)

A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2017)

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis
por: Tang, Zihan, et al.
Publicado: (2023)

Risk factors associated with relapse of adult-onset Still disease in Korean patients
por: Kang, Ji-Hyoun
Publicado: (2020)

An Unforeseen Outcome of COVID-19: The Triggering of Adult-Onset Still’s Disease
por: Alzuhaily, Hasan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i94577170mcrfoaekvch3knr81